Ausgabe 1/2022
Inhalt (36 Artikel)
Pivotal Trials in Multiple Sclerosis: Similarities Prove Not to Be Useful
Carlo Avolio, Diego Centonze
Caregiver Involvement in MS: Duty or Disruption?
Jürg Kesselring, Alexey Boyko, Alice Laroni, Trishna Bharadia, Pieter van Galen, Nektaria Alexandri
ANCA-Associated Vasculitic Neuropathies: A Review
Haruki Koike, Ryoji Nishi, Ken Ohyama, Saori Morozumi, Yuichi Kawagashira, Soma Furukawa, Naohiro Mouri, Yuki Fukami, Masahiro Iijima, Gen Sobue, Masahisa Katsuno
Effects of Pregnancy and Breastfeeding on Clinical Outcomes and MRI Measurements of Women with Multiple Sclerosis: An Exploratory Real-World Cohort Study
Lorena Lorefice, Marzia Fronza, Giuseppe Fenu, Jessica Frau, Giancarlo Coghe, Maurizio Nicola D’Alterio, Maria Antonietta Barracciu, Federica Murgia, Stefano Angioni, Eleonora Cocco
Use of a Novel EEG-Based Objective Test, the Cognalyzer®, in Quantifying the Strength and Determining the Action Time of Cannabis Psychoactive Effects and Factors that May Influence Them Within an Observational Study Framework
Dan Bosnyak, Alison C. McDonald, Israel Gasperin Haaz, Weikai Qi, David C. Crowley, Najla Guthrie, Malkanthi Evans
Risk Factors for Generalization in Patients with Ocular Myasthenia Gravis: A Multicenter Retrospective Cohort Study
Rong-Jing Guo, Ting Gao, Zhe Ruan, Hong-Yu Zhou, Feng Gao, Quan Xu, Li-Ping Yu, Song-Di Wu, Tao Lei, Huan-Huan Li, Chao Sun, Min Zhang, Yan-Wu Gao, Xiao-Dan Lu, Yong-Lan Tang, Bao-Li Tang, Fei-Yan Huo, Ying Zhu, Zhu-Yi Li, Ting Chang
Association Between Serum C1q Tumor Necrosis Factor-Related Protein 9 and the Clinical Characteristics and Prognosis of Ischemic Stroke
Cui Yang, Jia-yan Xin, Zhi-lan Liu, Fan Fan, Yun-ming Li, Fan Jin, Qing-song Wang, Fu-qiang Guo, Neng-wei Yu, Wei-dong Le, Yang Xiang
Functional Near-Infrared Spectroscopy as a Target Navigator for rTMS Modulation in Patients with Hemiplegia: A Randomized Control Study
Pang-Wei Chang, Chia-Feng Lu, Shin-Tsu Chang, Po-Yi Tsai
Network Meta-analysis of Food and Drug Administration-approved Treatment Options for Adults with Aquaporin-4 Immunoglobulin G-positive Neuromyelitis Optica Spectrum Disorder
Dean M. Wingerchuk, Ina Zhang, Adrian Kielhorn, Minying Royston, Michael Levy, Kazuo Fujihara, Ichiro Nakashima, Imran Tanvir, Friedemann Paul, Sean J. Pittock
Effective Rituximab Treatment in Patients with Neuromyelitis Optica Spectrum Disorders Compared with Azathioprine and Mycophenolate
Yang Yang, Lifeng Chen, Lei Wu, Jiarui Yao, Na Wang, Xiaoqing Su, Dongmei Li, Lina Han, Weiping Wu, Dehui Huang, Tianyu Jiang, Zhenfu Wang
Endovascular Treatment in Acute Ischemic Stroke with Large Vessel Occlusion According to Different Stroke Subtypes: Data from ANGEL-ACT Registry
Xiaochuan Huo, Dapeng Sun, Raynald, Baixue Jia, Xu Tong, Anxin Wang, Ning Ma, Feng Gao, Dapeng Mo, Gaoting Ma, Sheyar Amin, Zeguang Ren, Zhongrong Miao
Epidemiology, Demographics, Triptan Contraindications, and Prescription Patterns of Patients with Migraine: A German Claims Database Study
Astrid Gendolla, Nadine Rauer, Susanne Kraemer, Inka Schwerdtner, Andreas Straube
A Clinical Predictive Nomogram for Traumatic Brain Parenchyma Hematoma Progression
Jiangtao Sheng, Weiqiang Chen, Dongzhou Zhuang, Tian Li, Jinhua Yang, Shirong Cai, Xiaoxuan Chen, Xueer Liu, Fei Tian, Mindong Huang, Lianjie Li, Kangsheng Li
Burden of Migraine in Japan: Results of the ObserVational Survey of the Epidemiology, tReatment, and Care Of MigrainE (OVERCOME [Japan]) Study
Yasuhiko Matsumori, Kaname Ueda, Mika Komori, Anthony J. Zagar, Yongin Kim, Dena H. Jaffe, Takao Takeshima, Koichi Hirata
Erenumab Decreases Headache-Related Sick Leave Days and Health Care Visits: A Retrospective Real-World Study in Working Patients with Migraine
Henri Autio, Timo Purmonen, Samu Kurki, Emina Mocevic, Minna A. Korolainen, Samuli Tuominen, Mariann I. Lassenius, Markku Nissilä
Migraine and Ischemic Stroke: A Mendelian Randomization Study
Mei-Jun Shu, Jia-Rui Li, Yi-Cheng Zhu, Hang Shen
Evaluating the Economic Burden of Relapses in Neuromyelitis Optica Spectrum Disorder: A Real-World Analysis Using German Claims Data
Rachel K. Knapp, Fränce Hardtstock, Thomas Wilke, Ulf Maywald, Barthold Deiters, Sophie Schneider, Julie Mouchet
Deciphering the Network Effects of Deep Brain Stimulation in Parkinson's Disease
Gabriel Gonzalez-Escamilla, Nabin Koirala, Manuel Bange, Martin Glaser, Bogdan Pintea, Christian Dresel, Günther Deuschl, Muthuraman Muthuraman, Sergiu Groppa
Pharmacokinetics, Pharmacodynamics, and Tolerability of Opicapone in Healthy Chinese and Caucasian Subjects: An Open-Label, Single-Center, Phase 1 Study
Duanduan Cong, Jie Song, Yue Liu, Yan Tan, Wei Xue, Xiaohui Liu, Wenyuan Qi, Jun Lu, Xiaojuan Yuan, Yongchun Zhou, Ai-Min Hui, Kexin Li
Psychometric Properties of Clinical Indicators for Identification and Management of Advanced Parkinson’s Disease: Real-World Evidence From G7 Countries
Angelo Antonini, Rajesh Pahwa, Per Odin, Tove Henriksen, Michael J. Soileau, Ramon Rodriguez-Cruz, Stuart H. Isaacson, Aristide Merola, Susanna Lindvall, Josefa Domingos, Ali Alobaidi, Yash J. Jalundhwala, Prasanna L. Kandukuri, Juan Carlos Parra, Pavnit K. Kukreja, Koray Onuk, Lars Bergmann, James Pike, K. Ray Chaudhuri
Therapy Switches in Fingolimod-Treated Patients with Multiple Sclerosis: Long-Term Experience from the German MS Registry
Niklas Frahm, Firas Fneish, David Ellenberger, Peter Flachenecker, Friedemann Paul, Clemens Warnke, Christoph Kleinschnitz, Tina Parciak, Dagmar Krefting, Kerstin Hellwig, Judith Haas, Paulus S. Rommer, Alexander Stahmann, Uwe K. Zettl
Adherence to and Persistence with Disease-Modifying Therapies for Multiple Sclerosis Over 24 Months: A Retrospective Claims Analysis
Gabriel Pardo, Elmor D. Pineda, Carmen D. Ng, Komal K. Bawa, Daniel Sheinson, Nicole G. Bonine
Development of a Population Pharmacokinetic Model for the Diroximel Fumarate Metabolites Monomethyl Fumarate and 2-Hydroxyethyl Succinimide Following Oral Administration of Diroximel Fumarate in Healthy Participants and Patients with Multiple Sclerosis
Mita Kuchimanchi, Howard Bockbrader, Nancy Dolphin, Daniel Epling, Lauren Quinlan, Sunny Chapel, Natasha Penner
A Prospective, Observational, Multicenter Study Assessing Adherence to Interferon Beta-1b Therapy and Patient Satisfaction Using the BETACONNECT Auto-Injector
Ryan Farej, Mark Rametta, Anneliese La Rose, Apryl Quillen, Kim McLeod
A Principal Component Analysis Approach to Estimate the Disability Status for Patients with Multiple Sclerosis Using Japanese Claims Data
Izumi Kawachi, Hiromichi Otaka, Kosuke Iwasaki, Tomomi Takeshima, Kengo Ueda
MIND Diet Adherence Might be Associated with a Reduced Odds of Multiple Sclerosis: Results from a Case–Control Study
Morvarid Noormohammadi, Zeinab Ghorbani, Abdorreza Naser Moghadasi, Zahra Saeedirad, Sahar Shahemi, Milad Ghanaatgar, Nasim Rezaeimanesh, Azita Hekmatdoost, Amir Ghaemi, Soodeh Razeghi Jahromi
Staging Disease Severity Using the Alzheimer’s Disease Composite Score (ADCOMS): A Retrospective Data Analysis
Amir Abbas Tahami Monfared, Katherine Houghton, Quanwu Zhang, Josephine Mauskopf
Real-World Adherence to Tetrabenazine or Deutetrabenazine Among Patients With Huntington’s Disease: A Retrospective Database Analysis
Daniel O. Claassen, Rajeev Ayyagari, Viviana Garcia-Horton, Su Zhang, Jessica Alexander, Sam Leo
Comparative All-Cause Mortality Among a Large Population of Patients with Spinal Muscular Atrophy Versus Matched Controls
Emma Viscidi, Maneesh Juneja, Jin Wang, Nasha Wang, Li Li, Wildon Farwell, Ishir Bhan, Corinne Makepeace, Karen Laird, Varant Kupelian, Susan Eaton, Anne Dilley, Susan Hall
Durability of the Clinical Benefit of Droxidopa for Neurogenic Orthostatic Hypotension During 12 Weeks of Open-Label Treatment
Robert A. Hauser, Antonella Favit, L. Arthur Hewitt, Annika Lindsten, Stephen Gorny, Steven Kymes, Stuart H. Isaacson
No Changes in Functional Connectivity After Dimethyl Fumarate Treatment in Multiple Sclerosis
Claudia Piervincenzi, Emilia Sbardella, Marta Altieri, Antonio Ianniello, Patrizia Pantano, Carlo Pozzilli, Nikolaos Petsas
Low Fluctuation of Symptoms May Delay Diagnosis of Myasthenia Gravis: A Case Series
Andreea Dragusin, Nicolae Grecu, Athena Cristina Ribigan, Raluca Stefania Badea, Elena Oana Terecoasa, Amalia Ene, Cristina Tiu
Correction to: Low Fluctuation of Symptoms May Delay Diagnosis of Myasthenia Gravis: A Case Series
Andreea Dragusin, Nicolae Grecu, Athena Cristina Ribigan, Raluca Stefania Badea, Elena Oana Terecoasa, Amalia Ene, Cristina Tiu
Simultaneous Occurrence of Cerebral Venous Sinus Thrombosis and Immune Thrombocytopenic Purpura in a Patient with a History of COVID-19 Infection
Leyla Bahadorizadeh, Maziar Emamikhah, Arash Pour Mohammad, Milad Gholizadeh Mesgarha
Glial Fibrillary Acidic Protein (GFAP) Astrocytopathy Presenting as Mild Encephalopathy with Reversible Splenium Lesion
Charlotte Héraud, Nicolas Capet, Michaël Levraut, Robin Hattenberger, Véronique Bourg, Pierre Thomas, Lydiane Mondot, Christine Lebrun-Frenay
Marburg Multiple Sclerosis Variant: Complete Remission with Very Early Administration of Mitoxantrone—A Case Report
Nicolas Capet, Michael Levraut, Adrien Delourme, Oceane Thomel-Rocchi, Véronique Bourg, Philippe Cabre, Fanny Vandenbos, Lydiane Mondot, Christine Lebrun-Frenay